Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2002 (No. 1)
I, JOHN MENDOZA, Chief Executive of the Australian Sports Drug Agency, make these Orders under regulation 7B of the Australian Sports Drug Agency Regulations 1999.
Dated 2002
JOHN MENDOZA
Chief Executive of the Australian Sports Drug Agency
1 Name of Orders
These Orders are the Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2002 (No. 1).
2 Commencement
These Orders commence on gazettal.
3 Amendment of Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000
Schedule 1 amends the Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000.
Schedule 1 Amendment
(section 3)
Do not delete: Schedule Part Placeholder
[1] Section 5
substitute
5 Repeatedly not being satisfied
(1) If, for a provision in Part 2 of these Orders, a competitor must be satisfied of a matter in relation to an item mentioned in subsection (2) (for example, that an item of blood testing collection equipment has not been tampered with) and, after considering 3 items of the same kind, the competitor is not satisfied of the matter in relation to 1 of the items:
(a) the drug control official must instruct the competitor to choose another of the items from a number of items of the same kind; and
(b) 2 Agency representatives must decide if they are satisfied of the matter in relation to the item chosen under paragraph (a).
(2) For subsection (1), the items are:
(a) an item of blood testing collection equipment;
(b) a test kit;
(c) a part 1 sample bottle;
(d) a lid for a part 1 sample bottle;
(e) a part 2 sample bottle;
(f) a lid for a part 2 sample bottle.
(3) If the Agency representatives are not satisfied of the matter in relation to the item chosen under paragraph (1) (a), the steps mentioned in paragraphs (1) (a) and (b) must be repeated until the Agency representatives are so satisfied.
(4) A decision by 2 Agency representatives under paragraph (1) (b) or subsection (3) that they are satisfied of a matter in relation to an item is taken, for the purposes of this Scheme, to be a decision by the competitor that the competitor is satisfied of that matter in relation to that item.
(5) In this section, satisfied includes, if the case requires, reasonably satisfied.
Note This section is designed to prevent a competitor from frustrating the sample collection process by repeatedly refusing to be satisfied, for example, that an item of blood testing collection equipment has not been tampered with.
Overview
The Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2002 (No. 1) were enacted to refine and strengthen the drug testing procedures within the Australian Sports Drug Agency's Scheme B. These amendments were introduced to address issues where competitors could potentially hinder the drug testing process by repeatedly refusing to be satisfied with the integrity of testing equipment and materials. The Orders were made by John Mendoza, the Chief Executive of the Australian Sports Drug Agency, under the authority of regulation 7B of the Australian Sports Drug Agency Regulations 1999. The overarching policy objective of these amendments is to ensure a smooth and efficient drug testing process, thereby upholding the integrity of competitive sports in Australia.
Scope and Application
The Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2002 (No. 1) applies to the operations and procedures of the Australian Sports Drug Agency (ASADA) concerning drug testing in sports. These Orders modify the existing Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000, which themselves regulate the processes by which athletes and competitors are tested for performance-enhancing drugs. The amendment specifically addresses the circumstances under which a competitor may be required to choose different testing items if they repeatedly express dissatisfaction with the initial items provided. The jurisdictional reach of these Orders is national, applying across Australia as they pertain to the Commonwealth's regulatory framework for sports drug testing. The Orders do not specify any exclusions or exemptions, thus they apply broadly to all competitors subject to the testing regime. The application of these Orders is further extended through subordinate instruments as necessary, ensuring the enforcement of drug testing protocols remains effective and adaptable to operational challenges.
Key Provisions
The Australian Sports Drug Agency Drug Testing (Scheme B) Amendment Orders 2002 (No. 1) primarily amend the Australian Sports Drug Agency Drug Testing (Scheme B) Orders 2000. Specifically, Section 5 of these Orders provides detailed procedures for ensuring that competitors are satisfied with certain items used in drug testing. According to this section, if a competitor is not satisfied with an item related to blood testing collection equipment, a test kit, or sample bottles after considering three items of the same kind, the drug control official must instruct the competitor to choose another item from the available options. Furthermore, two Agency representatives must then determine if they are satisfied with the chosen item. If they are not satisfied, these steps must be repeated until they are. Importantly, a decision by the two Agency representatives that they are satisfied with the item is considered, for the purposes of this Scheme, as a decision by the competitor that they are satisfied with that item.
The Orders impose specific obligations on the parties involved in the drug testing process. Competitors are required to participate in the process of selecting and evaluating items used in drug testing. Drug control officials are tasked with ensuring that the process outlined in Section 5 is followed, while Agency representatives must make the final determination on whether a competitor is satisfied with the selected items. These obligations are designed to ensure that the drug testing process is conducted in a fair and transparent manner, minimising the potential for interference or tampering.
Breaches of these requirements can lead to various consequences. While the Orders do not explicitly detail offences or penalties for non-compliance, failure to adhere to the specified procedures could potentially result in the invalidation of test results, disciplinary action against the competitor, or other consequences as determined by the Australian Sports Drug Agency. Given the critical nature of drug testing in sports, adherence to these procedures is essential to maintain the integrity of the testing process and the fairness of competitive sports.